Immatics
Cancer immunotherapy research and development
- B2B
About Immatics
Company specializing in discovering cancer targets for immunotherapies, developing T cell receptors for enhanced response, offering Adoptive Cell Therapies, TCR Bispecifics, and pharmaceutical partnerships
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Tuebingen, Baden-Württemberg, Germany
- Founded
- 2000
- Revenue
- $21.6M – $171MTamtam estimate
- Website
- immatics.com
- linkedin.com/company/immatics
Immatics at a glance
Immatics is a B2B company in the Biotechnology Research industry, headquartered in Tuebingen, Baden-Württemberg, Germany.
Immatics was founded in 2000.
Immatics has 251–1,000 employees.
Immatics's revenue is $21.6M – $171M (Tamtam estimate).
Selling to companies like Immatics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies